[123I]-IMP SPECT findings in spinocerebellar ataxia type 6
Creators
- 1. Jikei Univ., Chiba (Japan). Kashiwa Hospital
Description
To study the dynamics of metabolic function in the cerebellar hemispheres, vermis and brain stem of patients with spinocerebellar ataxia type 6 (SCA6), we used single photon emission computed tomography (SPECT) with N-isopropyl-p-[123I] iodoamphetamine (IMP) to measure regional cerebral blood flow (rCBF) in six Japanese patients with SCA6 and nine normal control subjects. All patients with SCA6 were found to have expanded CAG repeats (from 22 to 24 repeats). The SPECT data were also analyzed semiquantitatively. The rCBF in the cerebellar hemisphere, vermis and brain stem was not significantly lower in patients with SCA6 than in normal controls. However, the ratio of the cerebellar hemisphere to occipital lobe (C/O ratio) was significantly lower in patients. The ratio of the vermis and brain stem to occipital lobe (V/O, P/O ratio) were not significantly lower in patients. The C/O, V/O and P/O ratio were especially sensitive indexes for regional cerebral function in patients with SCA6. Results of this study suggest that the functional decrease in SCA6 may begin in the cerebellar hemispheres. IMP SPECT was useful for evaluating rCBF in patients with SCA6. (author)
Additional details
Publishing Information
- Journal Title
- Tokyo Jikeikai Ika Daigaku Zasshi
- Journal Volume
- 115
- Journal Issue
- 1
- Journal Page Range
- p. 83-91
- ISSN
- 0375-9172
INIS
- Country of Publication
- Japan
- Country of Input or Organization
- Japan
- INIS RN
- 31025930
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BENZEDRINE; BIOLOGICAL FUNCTIONS; BLOOD FLOW; CEREBELLUM; COMPARATIVE EVALUATIONS; IODINE 123; METABOLISM; NERVOUS SYSTEM DISEASES; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; UPTAKE
- Descriptors DEC
- AMINES; AMPHETAMINES; ANALEPTICS; AUTONOMIC NERVOUS SYSTEM AGENTS; BETA DECAY RADIOISOTOPES; BODY; BRAIN; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM AGENTS; COMPUTERIZED TOMOGRAPHY; DISEASES; DRUGS; ELECTRON CAPTURE RADIOISOTOPES; EMISSION COMPUTED TOMOGRAPHY; EVALUATION; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPES; NERVOUS SYSTEM; NUCLEI; ODD-EVEN NUCLEI; ORGANIC COMPOUNDS; ORGANS; RADIOISOTOPES; SYMPATHOMIMETICS; TOMOGRAPHY